[COX-2 mediates U50488H-induced delayed cardioprotection in isolated rat heart]
- PMID: 16610083
- DOI: 10.3785/j.issn.1008-9292.2006.02.010
[COX-2 mediates U50488H-induced delayed cardioprotection in isolated rat heart]
Abstract
Objective: To determine whether U50488H, a selective agonist of kappa-opioid receptor, could induce biphasic (early and late) cardioprotection against myocardial ischemia/reperfusion injury and to explore the underlying mechanisms.
Methods: Isolated perfused rat hearts were subjected to 30 min of ischemia followed by 120 min reperfusion and the cardiac function was evaluated.
Result: Left ventricular end-diastolic pressure (LVEDP), left ventricular developed pressure (LVDP) and maximal velocity of contraction and relaxation (+/-dP/dtmax) were improved when U50488H was administered 1 or 24 h before ischemia (P<0.05). Myocardial infarct size, activities of creatine kinase (CK) and lactate dehydrogenase (LDH) in the coronary effluent were lower in the U50488H pretreatment group than those in the control group. Administration of a selective cyclooxygenase-2 (COX-2) inhibitor, celecoxib abolished the late phase of cardioprotection produced by administration of U50488H 24 h before ischemia. Activities of CK and LDH in the coronary effluent were higher in U50488H and celecoxib co-pretreatment group than those in U50488H group. However, administration of celecoxib did not block the early phase of cardioprotection by 1 h treatment of U50488H before ischemia.
Conclusion: The late (but not the early) phase of cardioprotection induced by kappa-opioid receptor agonist might be mediated by COX-2.
Similar articles
-
Quaternary ammonium salt of U50488H, a new κ-opioid receptor agonist, protects rat heart against ischemia/reperfusion injury.Eur J Pharmacol. 2014 Aug 15;737:177-84. doi: 10.1016/j.ejphar.2014.05.006. Epub 2014 May 20. Eur J Pharmacol. 2014. PMID: 24855042
-
Cardioprotective and antiarrhythmic effect of U50,488H in ischemia/reperfusion rat heart.Heart Vessels. 2007 Sep;22(5):335-44. doi: 10.1007/s00380-007-0983-z. Epub 2007 Sep 20. Heart Vessels. 2007. PMID: 17879026
-
Myocardial apoptosis and infarction after ischemia/reperfusion are attenuated by kappa-opioid receptor agonist.Arch Med Res. 2009 May;40(4):227-34. doi: 10.1016/j.arcmed.2009.04.009. Arch Med Res. 2009. PMID: 19608010
-
Roles of kappa opioid receptors in cardioprotection against ischemia: the signaling mechanisms.Sheng Li Xue Bao. 2003 Apr 25;55(2):115-20. Sheng Li Xue Bao. 2003. PMID: 12715097 Review.
-
Activation of kappa-opioid receptors at reperfusion affords cardioprotection in both rat and mouse hearts.Basic Res Cardiol. 2008 Sep;103(5):454-63. doi: 10.1007/s00395-008-0726-z. Epub 2008 May 23. Basic Res Cardiol. 2008. PMID: 18500486
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials